Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

1.45
-0.2300-13.69%
Post-market: 1.480.0300+2.07%18:15 EDT
Volume:5.51M
Turnover:8.20M
Market Cap:224.92M
PE:-1.16
High:1.66
Open:1.64
Low:1.44
Close:1.68
Loading ...

Humacyte Prices $50 Million Stock Offering

MT Newswires Live
·
26 Mar

Humacyte Shares Down 23.5% Premarket After Co Prices Public Offering of 25 Mln Shares at $2.00 per Share

THOMSON REUTERS
·
26 Mar

BRIEF-Humacyte Prices Public Offering Of 25 Million Shares At $2.00 Per Share

Reuters
·
26 Mar

Humacyte Inc - Prices Public Offering of 25 Mln Shares at $2.00 per Share

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
26 Mar

Humacyte's Stock Drops Below 52-Week Low Amidst Share Sale

Dow Jones
·
26 Mar

BUZZ-Humacyte tumbles on planned equity raise

Reuters
·
26 Mar

Humacyte Inc - to Use Proceeds for Symvess Commercialization, Pipeline Development, Working Capital

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
26 Mar

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
26 Mar

Humacyte Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
21 Mar

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

GlobeNewswire
·
10 Mar

Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research

MT Newswires Live
·
06 Mar

Humacyte, Trestle Biotherapeutics announce research collaboration

TIPRANKS
·
06 Mar

Trestle Bio Announces Research Collaboration With Humacyte

THOMSON REUTERS
·
06 Mar

Trestle Bio Announces Research Collaboration with Humacyte

Business Wire
·
06 Mar

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

GlobeNewswire
·
03 Mar

Humacyte Shares Rise After Receiving US Patent for Bioreactor Manufacturing System

MT Newswires Live
·
28 Feb

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess and Other Bioengineered Tissues

THOMSON REUTERS
·
27 Feb

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

GlobeNewswire
·
27 Feb